Global self-injections market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024.
The global self-injections market is expected to grow exponentially in the forecast period. The exponential growth is owing to multiple factors but the most prominent is development of biologic drugs for the treatment of autoimmune diseases, chronic diseases include heart disease, diabetes, stroke, and chronic respiratory problems. Due to the viscosity of biologic drugs the auto-injector is expected to serve as one of the best ways of drug delivery by self-injections.According to World Health Organization (WHO), there is over 5% of the global population suffering from autoimmune disease and the growing awareness among patients that new drugs being developed is expected to cure the disease in place of just suppressing the symptoms, the market will experience a rapid growth in the forecast years.
The self-injections market is segmented based on type, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.
On the basis of type, the global self-injections market is segmented into devices and formulations. The devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices. The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.
The needle-free injectors market is further segmented on the basis of product, technology, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into jet-based, spring-based, laser-powered, and vibration-based. The usability segment is further categorized into reusable and disposable.
The auto-injectors market is segmented into product, technology, design, and usability. The product segment is categorized into fillable and prefilled. The technology segment is further categorized into automated and manual. The design segment is further categorized into standardized and customized. The usability segment is further categorized into reusable and disposable.
The pen-injectors market is segmented into product, design, and usability. The product segment is categorized into single-chambered and dual-chambered. The design segment is further categorized into standard and customized. The usability segment is further categorized into reusable and disposable.
The formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting injection formulations. The conventional drug delivery segment is categorized into solutions, reconstituted/lyophilized formulations, suspensions and emulsions. The novel drug delivery formulations market is segmented into colloidal dispersions, and microparticles. Colloidal dispersions market is further categorized into liposomes, niosomes, and polymeric/mixed micelles, and nano particles. Also, nanoparticles market is further segmented into nanosuspensions, nanoemulsions/microemulsions, and solid-lipid nanoparticles.
Based on therapeutic application, the market is segmented intoautoimmunediseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others. The market is also segmented based on dosage formintosingle dose and multi-dose.
On the basis of route of administration, the market is segmented into skin, circulatory /musculoskeletal, organs, and central nervous system.
On the basis of end-user, the market is segmented into patient, physicians, home care settings and, others. The market is also segmented on the basis of distribution channel into hospital pharmacies, private clinics, chemist, and online pharmacies.
Based on geography, the self-injections market is segmented into geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa and, Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. North America is the largest market while Asia-Pacific is the fastest growing market due to the increase in incidence of chronic diseases, increasing health awareness,improving healthcare systems, and available disposable income.
The global self-injections market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are Abbvie, Inc., Antares Pharma, 3M, Becton Dickinson & Company, Baxter International Inc., Penjet Corporation, PharmaJet, GerresheimerAG,Pfizer Inc.,Terumo Corporation, Mylan N.V.,SHL Group,Bespak, Janssen Biotech Inc., Insulet Corporation, Unilife Corporation, West Pharmaceutical Services, Inc., Ypsomed, Eli lilly and Company,Haselmeier AG, Alkermes,AptarPharma,Credence MedSystems, Inc., SchottAG,Ypsomed, Owen Mumford Ltd., Glide Technologies,among other companies.